Mortality in prostate cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a new study. Results from the study show that prostate cancer mortality was 20 percent lower in counties with the highest incidence of prostate cancer, which indicates an early and rapid uptake of PSA testing.
Diagnostic Imaging Services offers a cutting-edge alternative for men who have had high PSA results but a negative prostate biopsy result. Our prostate 3T MRI study incorporates a digital imaging solution called DynaCAD, which works tremendously well in pinpointing areas of concern in the prostate gland. Many physicians use our study to guide a future biopsy, using more pinpointed accuracy in biopsying the area that was highlighted by our CAD solution.
To read the entire news report, visit https://www.sciencedaily.com/releases/2014/03/140310090749.htm